Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patients.
Saved in:
| Title: | Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patients. |
|---|---|
| Authors: | Reyes-González J; Precision Translational Oncology Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico., Barajas-Olmos F; Immunogenomics and Metabolic Diseases Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico., García-Ortiz H; Immunogenomics and Metabolic Diseases Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico., Magraner-Pardo L; Gene Function Team, The Institute of Cancer Research (ICR), London, UK., Pons T; Department of Immunology and Oncology, National Center for Biotechnology, Spanish National Research Council (CNB-CSIC), Madrid, Spain., Moreno S; Radioneurosurgery Unit, National Institute of Neurology and Neurosurgery; Mexico City, Mexico., Aguirre-Cruz L; Neuroendocrinology Laboratory, National Institute of Neurology and Neurosurgery; Mexico City, Mexico., Reyes-Abrahantes A; Precision Translational Oncology Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico., Martínez-Hernández A; Immunogenomics and Metabolic Diseases Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico., Contreras-Cubas C; Immunogenomics and Metabolic Diseases Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico., Barrios-Payan J; Department of Pathology, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, Mexico., Ruiz-Garcia H; Department of Neurosurgery and Brain Tumor Stem Cell Research Laboratory, Mayo Clinic, Jacksonville, Florida,USA., Hernandez-Pando R; Department of Pathology, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, Mexico., Quiñones-Hinojosa A; Department of Neurosurgery and Brain Tumor Stem Cell Research Laboratory, Mayo Clinic, Jacksonville, Florida,USA., Orozco L; Immunogenomics and Metabolic Diseases Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico., Abrahantes-Pérez MDC; Precision Translational Oncology Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico. |
| Source: | Neuro-oncology [Neuro Oncol] 2023 Feb 14; Vol. 25 (2), pp. 303-314. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1523-5866 |
|---|---|
| DOI: | 10.1093/neuonc/noac171 |
